A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer
| Autor: | Shaoying Lu, Huan Jia, Yan Li, Yanan Tang, Hao Guan, Thomas D. Wang, Dan Zhang, Jichang Wang, Weiming Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Oncology
Male Pathology Microarray diagnosis Peptide binding Kaplan-Meier Estimate Mice 0302 clinical medicine CD44 Tissue microarray biology Antibodies Monoclonal Middle Aged Prognosis Hyaluronan Receptors 030220 oncology & carcinogenesis Monoclonal Heterografts 030211 gastroenterology & hepatology Female Antibody Research Paper Protein Binding Adult medicine.medical_specialty Cell Survival 03 medical and health sciences RP-1 Cancer stem cell Stomach Neoplasms Internal medicine Cell Line Tumor medicine Biomarkers Tumor Animals Humans Aged Neoplasm Staging Proportional Hazards Models business.industry gastric cancer Cancer medicine.disease Disease Models Animal Cancer cell biology.protein Neoplasm Grading business Antimicrobial Cationic Peptides |
| Zdroj: | Oncotarget |
| ISSN: | 1949-2553 |
| Popis: | // Weiming Li 1, * , Huan Jia 2, * , Jichang Wang 1 , Hao Guan 1 , Yan Li 1 , Dan Zhang 3 , Yanan Tang 1 , Thomas D. Wang 4 , Shaoying Lu 1 1 Department of Vascular Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, 710061, P.R.China 2 Department of General Surgery, The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi Province, 710077, P.R.China 3 Department of Gastroenterology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, 710061, P.R.China 4 Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA * Co-first authors, These authors contributed equally to this work Correspondence to: Shaoying Lu, email: robertlu@mail.xjtu.edu.cn Keywords: RP-1, CD44, gastric cancer, diagnosis, prognosis Received: September 22, 2016 Accepted: March 09, 2017 Published: March 16, 2017 ABSTRACT Early diagnosis and evaluation of prognosis are both crucial for preventing poor prognosis of patients with gastric cancer (GC), a leading cause of cancer-related deaths worldwide. Cluster of differentiation 44 (CD44), an indicator of cancer stem cells, can be specifically targeted by molecular probes and detected in tissues of GC in a large quantity. In current study we found that RP-1, a specific peptide binding to CD44 protein, exhibited the potentials of specific binding to CD44 high-expressing cancer cells both in vitro and in vivo , and the capacity of predicting prognosis of human GC in a microarray assay. Results showed that RP-1 was characterized by high affinity, sensitivity and specificity, and low toxicity, suggesting RP-1 could be an ideal bio-probe for accessory diagnosis of GC. Further immunohistochemical studies and statistical analysis of tissue microarray of human GC demonstrated similar sensitivity and specificity of RP-1 with the monoclonal anti-CD44 antibody in the diagnosis of GC, and even proved that positive RP-1 could be an independent risk factor. Therefore, this study suggests RP-1 has the potentials of binding to CD44 protein expressed on the membrane of GC cells, and demonstrates the feasibility and reliability of its further application in molecular diagnosis and prognostic prediction of GC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|